HLB바이오스텝
5,990KRWMarket close of 10/20 (Tue)
Down -0.17%-10KRWMarket close of 10/20 (Tue)
Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/21 (Wed)6,010KRWUp +0.33%
Preliminary · just after the close · replaced by official KRX data tomorrow morning
- Open
- 6,000
- High
- 6,450
- Low
- 5,720
- Day range
- Day range low 5,720 high 6,450, open 6,000, close 5,990, previous close 6,000
- Volume
- 99×10K shares
- 6.0B KRW 0.41× the 20-session average
Market close of 10/20 (Tue)
Something to check
1 to check: operating loss
Free · no sign-inSource from 2021-05-17
Points to check
- Earningsto check-8.7B KRWOperating income over the last four quarters -8.7B KRW (loss)
- Daily movenot verifiedOnly 14 daily bars to compare, so not verified
- Trading valuenot verifiedNot enough 20-session trading value data, so not verified
The other 3
- Recent filingsnot verified
- Foreign & institutionalnot verified
- Data date10/20 (Tue)Market close
See the full check report
Quarterly results · Q1 2026
- Revenue13.5B KRW
- vs. year ago
- -0.7%
- vs. prior quarter
- -28.0%
- Operating income-2.6B KRW
- vs. year ago
- Still a loss
- vs. prior quarter
- Still a loss
- Operating margin-19.4%
- vs. year ago
- -0.6 pp
- vs. prior quarter
- -7.5 pp
Quarterly operating income trend
As of the latest official close · 2026-10-20Valuation filing date · 2026-05-15Same sector · 바이오 R&D
Down -2.19%· 16 of 64 stocks up, preferred shares excluded · trading value 190.5B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 알테오젠 | Close over the last 20 sessions -9.6% | Down -3.35% | 51.1B KRW |
| 올릭스 | Close over the last 20 sessions -12.2% | Down -4.03% | 19.1B KRW |
| 디앤디파마텍 | Close over the last 20 sessions -11.8% | Down -1.93% | 15.1B KRW |
| 리가켐바이오 | Close over the last 20 sessions -15.4% | Down -1.41% | 12.1B KRW |
| 프로티나 | Close over the last 20 sessions +31.8% | Up +7.38% | 10.0B KRW |
Schedule
- Next data 10/22 (Thu) after 08:50
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 81% of trading value, about 92% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.